BackLongboard Pharmaceuticals Overview

Longboard Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for LBPH.

Quarterly SG&A Expenses

$6.67M
↑ 115.71% YoY

As of Sep 30, 2024

Annual SG&A Expenses (TTM)

$20.19M
↑ 65.92% YoY

Trailing 12 months ending Sep 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin